$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 51/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 51/2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 20 2016 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 381.92 | 78,302 | 29,905,100 | 78,302 | |
Dec 20 2016 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 59,788 | 0 | 414,156 | 473.9 K to 414.2 K (-12.61 %) |
Dec 20 2016 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 381.92 | 58,342 | 22,281,977 | 58,342 | |
Dec 20 2016 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 7,876 | 0 | 23,950 | 31.8 K to 24 K (-24.75 %) |
Dec 20 2016 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 1,500 | 0 | 40,470 | 42 K to 40.5 K (-3.57 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 381.92 | 24,565 | 9,381,865 | 24,565 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | A | 381.92 | 21,675 | 8,278,116 | 21,675 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | EVP & General Mgr I ... | Option Exercise | A | 381.92 | 34,000 | 12,985,280 | 34,000 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | A | 381.92 | 34,000 | 12,985,280 | 34,000 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | A | 381.92 | 5,000 | 1,909,600 | 5,000 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Gift | G | 0.00 | 2,459 | 0 | 2,459 | 0 to 2.5 K |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Gift | G | 0.00 | 2,459 | 0 | 2,459 | 0 to 2.5 K |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Gift | G | 0.00 | 2,459 | 0 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Gift | G | 0.00 | 2,459 | 0 | 2,459 | 4.9 K to 2.5 K (-50.00 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | A | 381.92 | 24,565 | 9,381,865 | 24,565 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 381.92 | 146,815 | 56,071,585 | 146,815 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 20.32 | 195,079 | 3,964,005 | 0 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 500,000 | 0 | 67,976 | 568 K to 68 K (-88.03 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 380.09 | 95,223 | 36,193,310 | 591,348 | 686.6 K to 591.3 K (-13.87 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Payment of Exercise | F | 380.09 | 10,429 | 3,963,959 | 686,571 | 697 K to 686.6 K (-1.50 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 20.32 | 195,079 | 3,964,005 | 697,000 | 501.9 K to 697 K (+38.87 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 381.92 | 146,815 | 56,071,585 | 146,815 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | M | 20.32 | 250,000 | 5,080,000 | 0 | |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 380.09 | 122,032 | 46,383,143 | 157,409 | 279.4 K to 157.4 K (-43.67 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Payment of Exercise | F | 380.09 | 13,365 | 5,079,903 | 279,441 | 292.8 K to 279.4 K (-4.56 %) |
Dec 19 2016 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Buy | M | 20.32 | 250,000 | 5,080,000 | 292,806 | 42.8 K to 292.8 K (+584.03 %) |